144 related articles for article (PubMed ID: 21176857)
1. The relationship between adipocyte fatty acid binding protein-4, retinol binding protein-4 levels and early diabetic nephropathy in patients with type 2 diabetes.
Toruner F; Altinova AE; Akturk M; Kaya M; Arslan E; Bukan N; Kan E; Yetkin I; Arslan M
Diabetes Res Clin Pract; 2011 Feb; 91(2):203-7. PubMed ID: 21176857
[TBL] [Abstract][Full Text] [Related]
2. Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes.
Cabré A; Lázaro I; Girona J; Manzanares J; Marimón F; Plana N; Heras M; Masana L
J Intern Med; 2007 Oct; 262(4):496-503. PubMed ID: 17875187
[TBL] [Abstract][Full Text] [Related]
3. Levels of retinol-binding protein 4 and uric acid in patients with type 2 diabetes mellitus.
Chen CC; Wu JY; Chang CT; Tsai FJ; Wang TY; Liu YM; Tsui HC; Chen RH; Chiou SC
Metabolism; 2009 Dec; 58(12):1812-6. PubMed ID: 19709697
[TBL] [Abstract][Full Text] [Related]
4. Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Wu H; Jia W; Bao Y; Lu J; Zhu J; Wang R; Chen Y; Xiang K
Diabetes Res Clin Pract; 2008 Feb; 79(2):185-90. PubMed ID: 17904683
[TBL] [Abstract][Full Text] [Related]
5. Serum Adipocyte Fatty Acid-Binding Protein 4 Levels Are Independently Associated with Radioisotope Glomerular Filtration Rate in Type 2 Diabetic Patients with Early Diabetic Nephropathy.
Ni X; Gu Y; Yu H; Wang S; Chen Y; Wang X; Yuan X; Jia W
Biomed Res Int; 2018; 2018():4578140. PubMed ID: 29992142
[TBL] [Abstract][Full Text] [Related]
6. An increase in serum retinol-binding protein 4 in the type 2 diabetic subjects with nephropathy.
Murata M; Saito T; Otani T; Sasaki M; Ikoma A; Toyoshima H; Kawakami M; Ishikawa SE
Endocr J; 2009; 56(2):287-94. PubMed ID: 19122345
[TBL] [Abstract][Full Text] [Related]
7. Free fatty acid binding protein-4 and retinol binding protein-4 in polycystic ovary syndrome: response to simvastatin and metformin therapies.
Karakas SE; Banaszewska B; Spaczynski RZ; Pawelczyk L; Duleba A
Gynecol Endocrinol; 2013 May; 29(5):483-7. PubMed ID: 23480783
[TBL] [Abstract][Full Text] [Related]
8. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
[TBL] [Abstract][Full Text] [Related]
9. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass.
Gómez-Ambrosi J; Rodríguez A; Catalán V; Ramírez B; Silva C; Rotellar F; Gil MJ; Salvador J; Frühbeck G
Clin Endocrinol (Oxf); 2008 Aug; 69(2):208-15. PubMed ID: 18081728
[TBL] [Abstract][Full Text] [Related]
10. [An association between adiponectin and renal dysfunction in patients with type 2 diabetes mellitus].
Galovičová A; Lazúrová I; Petrášová D
Vnitr Lek; 2012 Nov; 58(11):825-9. PubMed ID: 23256827
[TBL] [Abstract][Full Text] [Related]
11. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
[TBL] [Abstract][Full Text] [Related]
12. Estimated glomerular filtration rate and its association with the retinol-binding protein 4 (RBP4) locus on human chromosome 10q23.
Ng DP; Salim A; Lim XL; Nurbaya S
Nephrol Dial Transplant; 2012 Apr; 27(4):1511-5. PubMed ID: 21821833
[TBL] [Abstract][Full Text] [Related]
13. [Relations of serum adipocyte fatty acid binding protein to sex hormone and lipoproteins in patients with polycystic ovary syndrome].
Hu WH; Qiao J; Li R; Wang LN
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(45):3186-9. PubMed ID: 17313783
[TBL] [Abstract][Full Text] [Related]
14. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
Saraheimo M; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Heikkilä O; Hietala K; Gordin D; Frystyk J; Flyvbjerg A; Groop PH;
Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
[TBL] [Abstract][Full Text] [Related]
15. The comparison of cystatin C and creatinine as an accurate serum marker in the prediction of type 2 diabetic nephropathy.
Lee BW; Ihm SH; Choi MG; Yoo HJ
Diabetes Res Clin Pract; 2007 Dec; 78(3):428-34. PubMed ID: 17822797
[TBL] [Abstract][Full Text] [Related]
16. Plasma fatty acid-binding protein 4 increases with renal dysfunction in type 2 diabetic patients without microalbuminuria.
Cabré A; Lázaro I; Girona J; Manzanares JM; Marimón F; Plana N; Heras M; Masana L
Clin Chem; 2008 Jan; 54(1):181-7. PubMed ID: 18024526
[TBL] [Abstract][Full Text] [Related]
17. Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients.
Ulgen F; Herder C; Kühn MC; Willenberg HS; Schott M; Scherbaum WA; Schinner S
Arch Physiol Biochem; 2010 May; 116(2):57-62. PubMed ID: 20222849
[TBL] [Abstract][Full Text] [Related]
18. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.
Stefan N; Hennige AM; Staiger H; Machann J; Schick F; Schleicher E; Fritsche A; Häring HU
Diabetes Care; 2007 May; 30(5):1173-8. PubMed ID: 17259477
[TBL] [Abstract][Full Text] [Related]
19. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial.
Azadbakht L; Atabak S; Esmaillzadeh A
Diabetes Care; 2008 Apr; 31(4):648-54. PubMed ID: 18184902
[TBL] [Abstract][Full Text] [Related]
20. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
Takebayashi K; Matsumoto S; Aso Y; Inukai T
J Diabetes Complications; 2006; 20(2):98-104. PubMed ID: 16504838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
